Volume 26 Archives - Page 11 of 49 - IBO

Process Analysis and Bioprocess Analysis

January 31, 2018/0 Comments/in Volume 26, Issue 20 Process Analysis News Items Volume 26 /by admin

Pall announces two partnerships

QIAGEN to Acquire Platform for Syndromic Testing

January 31, 2018/0 Comments/in Volume 26, Issue 20 Clinical, M&A Executive Briefing, Mergers and Acquisitions Executive Briefing Volume 26 /by admin

New multiplex technology scheduled to launch later this year

Thermo Fisher Scientific Launches Ion GeneStudio S5 Series

January 31, 2018/0 Comments/in Volume 26, Issue 20 Sequencing Articles Volume 26 /by Tanya Samazan

Next-generation Ion GeneStudio S5 Series offers more flexibility and more cost savings – Contributing author: Al Saint Jacques

Abcam and Tecan Present at JP Morgan Conference

January 31, 2018/0 Comments/in Volume 26, Issue 20 Financial Online only Volume 26 /by admin

Companies focused on change

UK

January 31, 2018/0 Comments/in Volume 26, Issue 20 Europe Region Watch Volume 26 /by admin

Fate of pharmaceutical industry in post-Brexit UK remains unclear

Third Quarter Results: BD, Bio-Rad, Biotage and Shimadzu

January 31, 2018/0 Comments/in Volume 26, Issue 20 Financial Financial Volume 26 /by admin

Robust third quarter sales for life science companies

Pharmaceuticals

January 30, 2018/0 Comments/in Volume 26, Issue 20 Pharmaceutical Industry Watch Volume 26 /by admin

Life science M&A deals forecast to rise in 2018, according to EY report

Oil

January 29, 2018/0 Comments/in Volume 26, Issue 20 Industry Watch Volume 26 /by admin

Bioplastics industry forecast to significantly affect oil demand

Government

January 29, 2018/0 Comments/in Volume 26, Issue 20 Government Industry Watch Volume 26 /by admin

FDA reforming regulation process for generic drugs

Japan

January 26, 2018/0 Comments/in Volume 26, Issue 20 Asia-Pacific Region Watch Volume 26 /by admin

Japan plans genomics-based treatments for patients through hospital collaborations